Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study

Similar Items

• Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries
  by: Chow C.K.; Nguyen T.N.; Marschner S.; Diaz R.; Rahman O.; Avezum A.; Lear S.A.; Teo K.; Yeates K.E.; Lanas F.; Li W.; Hu B.; Lopez-Jaramillo P.; Gupta R.; Kumar R.; Mony P.K.; Bahonar A.; Yusoff K.; Khatib R.; Kazmi K.; Dans A.L.; Zatonska K.; Alhabib K.F.; Kruger I.M.; Rosengren A.; Gulec S.; Yusufali A.; Chifamba J.; Rangarajan S.; McKee M.; Yusuf S.
  Published: (2020)
• Association of Sitting Time with Mortality and Cardiovascular Events in High-Income, Middle-Income, and Low-Income Countries
  by: Li S.; Lear S.A.; Rangarajan S.; Hu B.; Yin L.; Bangdiwala S.I.; Alhabib K.F.; Rosengren A.; Gupta R.; Mony P.K.; Wielgosz A.; Rahman O.; Mazapuspavina M.Y.; Avezum A.; Oguz A.; Yeates K.; Lanas F.; Dans A.; Abat M.E.M.; Yusufali A.; Diaz R.; Lopez-Jaramillo P.; Leach L.; Lakshmi P.V.M.; Basiak-Rasała A.; Iqbal R.; Kelishadi R.; Chifamba J.; Khatib R.; Li W.; Yusuf S.
  Published: (2022)
• Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study
  by: Chow C.K.; Ramasundarahettige C.; Hu W.; AlHabib K.F.; Avezum A., et al.
  Published: (2018)
• Metabolic, behavioural, and psychosocial risk factors and cardiovascular disease in women compared with men in 21 high-income, middle-income, and low-income countries: an analysis of the PURE study
  by: Walli-Attaei M.; Rosengren A.; Rangarajan S.; Breet Y.; Abdul-Razak S.; Sharief W.A.; Alhabib K.F.; Avezum A.; Chifamba J.; Diaz R.; Gupta R.; Hu B.; Iqbal R.; Ismail R.; Kelishadi R.; Khatib R.; Lang X.; Li S.; Lopez-Jaramillo P.; Mohan V.; Oguz A.; Palileo-Villanueva L.M.; Poltyn-Zaradna K.; R S.P.; Pinnaka L.V.M.; Serón P.; Teo K.; Verghese S.T.; Wielgosz A.; Yeates K.; Yusuf R.; Anand S.S.; Yusuf S.
  Published: (2022)
• Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: An analysis of the PURE study data
  by: Khatib R.; McKee M.; Shannon H.; Chow C.; Rangarajan S.; Teo K.; Wei L.; Mony P.; Mohan V.; Gupta R.; Kumar R.; Vijayakumar K.; Lear S.A.; Diaz R.; Avezum A.; Lopez-Jaramillo P.; Lanas F.; Yusoff K.; Ismail N.; Kazmi K.; Rahman O.; Rosengren A.; Monsef N.; Kelishadi R.; Kruger A.; Puoane T.; Szuba A.; Chifamba J.; Temizhan A.; Dagenais G.; Gafni A.; Yusuf S.
  Published: (2016)